Peter W. Fan

1.4k total citations
35 papers, 829 citations indexed

About

Peter W. Fan is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Peter W. Fan has authored 35 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Peter W. Fan's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (8 papers) and Estrogen and related hormone effects (5 papers). Peter W. Fan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (8 papers) and Estrogen and related hormone effects (5 papers). Peter W. Fan collaborates with scholars based in United States, Canada and China. Peter W. Fan's co-authors include Judy L. Bolton, Jeffrey Stevens, Daniel C. Kemp, Fagen Zhang, S. Cyrus Khojasteh, Richard B. van Breemen, Bill J. Smith, Bernard P. Murray, Bhagwat Prasad and Abdul Basit and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Peter W. Fan

35 papers receiving 805 citations

Peers

Peter W. Fan

PHARM

ONCOL

GENET

Chen Cheng China

Fan‐hao Meng China

Bahaa Elgendy United States

Mengmeng Ning China

Jian‐Fang Cui China

Qingzhong Hu Germany

Fuhao Chu China

Luigi Quintieri Italy

Richard Voorman United States

Tang Li-da China

Chen Cheng China

Peter W. Fan

180 ×0.6

PHARM

686 ×2.7

596 ×2.6

ONCOL

105 ×0.6

160 ×1.1

GENET

Citations per year, relative to Peter W. Fan Peter W. Fan (= 1×) peers Chen Cheng

Countries citing papers authored by Peter W. Fan

Since Specialization

Citations

This map shows the geographic impact of Peter W. Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Fan more than expected).

Fields of papers citing papers by Peter W. Fan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Fan. The network helps show where Peter W. Fan may publish in the future.

Co-authorship network of co-authors of Peter W. Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Fan. A scholar is included among the top collaborators of Peter W. Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Fan. Peter W. Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basit, Abdul, Peter W. Fan, S. Cyrus Khojasteh, et al.. (2021). Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species. Drug Metabolism and Disposition. 50(3). 197–203. 23 indexed citations

Basit, Abdul, Albert P. Li, Peter W. Fan, et al.. (2020). Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine. Drug Metabolism and Disposition. 48(7). 528–536. 28 indexed citations

Yu, Hongshi, et al.. (2019). Estimation of Fraction Dissolved After Intratracheal Delivery of a Potent Janus Kinase Inhibitor, iJAK-001, with Low Solubility in Rat and Sheep: Impact of Preclinical PKPD on Inhaled Human Dose Projection. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(5). 251–265. 4 indexed citations

Lutz, Ryan, et al.. (2019). Carboxylesterase catalyzed 18O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites. Drug Metabolism and Pharmacokinetics. 34(5). 308–316. 8 indexed citations

Chiang, Po‐Chang, et al.. (2018). Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans. Journal of Pharmaceutical Sciences. 107(7). 1798–1805. 14 indexed citations

Chiang, Po‐Chang, et al.. (2018). Investigation of Drug Delivery in Rats via Subcutaneous Injection: Case Study of Pharmacokinetic Modeling of Suspension Formulations. Journal of Pharmaceutical Sciences. 108(1). 109–119. 13 indexed citations

Mao, Jialin, Peter W. Fan, Susan Wong, et al.. (2017). Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound. Pharmaceutical Research. 34(11). 2403–2414. 3 indexed citations

Dragovich, Peter S., Fabio Broccatelli, Jinhua Chen, et al.. (2017). Design, synthesis, and biological evaluation of pyrrolobenzodiazepine-containing hypoxia-activated prodrugs. Bioorganic & Medicinal Chemistry Letters. 27(23). 5300–5304. 9 indexed citations

Fan, Peter W., Dawei Zhang, Jason Halladay, James P. Driscoll, & S. Cyrus Khojasteh. (2016). Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase. Drug Metabolism and Disposition. 44(8). 1253–1261. 19 indexed citations

10.

Fan, Peter W., Jacob Chen, Hank La, et al.. (2016). Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat. Drug Metabolism Letters. 10(2). 91–100. 5 indexed citations

11.

Le, Hoa Thi, Peter W. Fan, Susan Wong, et al.. (2016). Elucidating the Mechanism of Tofacitinib Oxidative Decyanation. Drug Metabolism Letters. 10(2). 136–143. 6 indexed citations

12.

Hanan, Emily J., Marian C. Bryan, Yuan Chen, et al.. (2015). 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 26(2). 534–539. 39 indexed citations

13.

Johnson, Michael G., Jim Liu, An‐Rong Li, et al.. (2014). Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP. Bioorganic & Medicinal Chemistry Letters. 24(13). 2877–2880. 1 indexed citations

14.

Le, Hoa Thi, Kevin A. Ford, S. Cyrus Khojasteh, & Peter W. Fan. (2012). Elucidation of the mechanism of ribose conjugation in a pyrazole-containing compound in rodent liver. Xenobiotica. 43(3). 236–245. 3 indexed citations

15.

Du, Xiaohui, Mike E. Lizarzaburu, Simon Turcotte, et al.. (2011). Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3774–3779. 13 indexed citations

16.

Zhang, Chenghong, Jane R. Kenny, Hoa Thi Le, et al.. (2011). Novel Mechanism for Dehalogenation and Glutathione Conjugation of Dihalogenated Anilines in Human Liver Microsomes: Evidence foripsoGlutathione Addition. Chemical Research in Toxicology. 24(10). 1668–1677. 11 indexed citations

17.

Wong, Simon, Peter W. Fan, Raju Subramanian, et al.. (2010). Bioactivation of a Novel 2-Methylindole-Containing Dual Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type-2 Cells/d-Prostanoid Receptor Antagonist Leads to Mechanism-Based CYP3A Inactivation: Glutathione Adduct Characterization and Prediction of In Vivo Drug-Drug Interaction. Drug Metabolism and Disposition. 38(5). 841–850. 9 indexed citations

18.

Fan, Peter W., et al.. (2004). Diffusional Dissolution of Alumina in Various Steelmaking Slags. ISIJ International. 44(2). 229–234. 54 indexed citations

19.

Fan, Peter W., et al.. (2003). Mechanism-Based Inactivation of Cytochrome P450 2B6 by a Novel Terminal Acetylene Inhibitor. Drug Metabolism and Disposition. 31(1). 28–36. 15 indexed citations

20.

Kemp, Daniel C., Peter W. Fan, & Jeffrey Stevens. (2002). Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance. Drug Metabolism and Disposition. 30(6). 694–700. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact